BrightGene
VC Fund
Beijing, China
BrightGene is a VC fund in Beijing focused on Biotechnology and Genetics. BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries BrightGene invests in
Stages BrightGene invests in
Countries BrightGene invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Yuan Lai Zou
|
|||
Investment Focus
Industry
- Biotechnology 2 (100%)
- Genetics 1 (50%)
- Biopharma 1 (50%)
- Health Care 1 (50%)
Country
- China 1 (50%)
- United States 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Yuan Lai Zou
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Aoli Biotechnology
|
Aoli Biotechnology is a biopharmaceutical oral delivery technology provider. Aoli Biotechnology focuses on research into macromolecule oral delivery technology and has developed a number of world-leading excipient technology patents, including soteria and phloral technology. | Seed / Jan 29, 2024 | |
DNALite Therapeutics
|
DNALite Therapeutics, Inc. is an early-stage preclinical biotechnology company committed on bringing the next-generation of drugs to the gastrointestinal tract. Currently for some gastrointestinal diseases, such as colorectal cancer and Crohn's disease, complete or partial removal of the colon and/or rectum is the only treatment Our aimis to prevent not manage the progression of theses diseases. We are doing this by harnessing our proprietary technology to carry DNA to cells that drive these diseases. | $1.5M / Seed / Aug 08, 2018 |
Co-Investors
Berkeley Catalyst Fund (BCF)
1 deal together
BIOCHING CAPITAL
1 deal together
Blue Bear Ventures
1 deal together
Highlight Capital
1 deal together
SOSV
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does BrightGene invest in?
BrightGene invests primarily in Biotechnology, Genetics and Biopharma startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BrightGene?
Public channels for BrightGene include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BrightGene?
The team at BrightGene includes Yuan Lai Zou (Chief Financial Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
